title: Virologic and immunologic efficacy of the tenofovir/didanosine/lamivudine regimen.
authors.forename: Romina
authors.initials: R
authors.lastname: Quercia
authors.forename: Corinne
authors.initials: C
authors.lastname: Amiel
authors.forename: Elisete Da Silva
authors.initials: Eda S
authors.lastname: Marechal
authors.forename: Marie-Gisèle
authors.initials: MG
authors.lastname: Lebrette
authors.forename: Sandrine
authors.initials: S
authors.lastname: Thevenet
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Renaud
authors.forename: Véronique
authors.initials: V
authors.lastname: Schneider
authors.forename: Ali
authors.initials: A
authors.lastname: Kara
authors.forename: Sabine
authors.initials: S
authors.lastname: Guessant
authors.forename: Gilles
authors.initials: G
authors.lastname: Pialoux
mesh_terms: D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D016049:Didanosine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use*; D063065:Organophosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000068698:Tenofovir
chemical_list: D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D000068698:Tenofovir; D000225:Adenine; D016049:Didanosine